The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 5, Issue 9, Pages e1412-e1412
Publisher
Springer Nature
Online
2014-09-11
DOI
10.1038/cddis.2014.379
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Bcl-2/xL inhibitor ABT-263 increases the stability of Mcl-1 mRNA and protein in hepatocellular carcinoma cells
- (2014) Bin Wang et al. Molecular Cancer
- Noxa determines localization and stability of MCL-1 and consequently ABT-737 sensitivity in small cell lung cancer
- (2014) W Nakajima et al. Cell Death & Disease
- The putative BH3 mimetic S1 sensitizes leukemia to ABT-737 by increasing reactive oxygen species, inducing endoplasmic reticulum stress, and upregulating the BH3-only protein NOXA
- (2013) Ryan Soderquist et al. APOPTOSIS
- Caloric restriction modulates Mcl-1 expression and sensitizes lymphomas to BH3 mimetic in mice
- (2013) O. Meynet et al. BLOOD
- BH3 Mimetics: Status of the Field and New Developments
- (2013) C. Billard MOLECULAR CANCER THERAPEUTICS
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
- (2013) Peter E. Czabotar et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Bcl-2, Bcl-xL, and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells
- (2012) D. Merino et al. BLOOD
- A Competitive Stapled Peptide Screen Identifies a Selective Small Molecule that Overcomes MCL-1-Dependent Leukemia Cell Survival
- (2012) Nicole A. Cohen et al. CHEMISTRY & BIOLOGY
- Discovery of Marinopyrrole A (Maritoclax) as a Selective Mcl-1 Antagonist that Overcomes ABT-737 Resistance by Binding to and Targeting Mcl-1 for Proteasomal Degradation
- (2012) Kenichiro Doi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mcl-1 and FBW7 Control a Dominant Survival Pathway Underlying HDAC and Bcl-2 Inhibitor Synergy in Squamous Cell Carcinoma
- (2012) Lei He et al. Cancer Discovery
- p53-dependent regulation of Mcl-1 contributes to synergistic cell death by ionizing radiation and the Bcl-2/Bcl-XL inhibitor ABT-737
- (2011) Katrin E. Tagscherer et al. APOPTOSIS
- Fas death receptor signalling: roles of Bid and XIAP
- (2011) T Kaufmann et al. CELL DEATH AND DIFFERENTIATION
- Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
- (2011) L Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Modulation of NOXA and MCL-1 as a Strategy for Sensitizing Melanoma Cells to the BH3-Mimetic ABT-737
- (2011) K. M. Lucas et al. CLINICAL CANCER RESEARCH
- Cellular FLICE-inhibitory Protein (cFLIP) Isoforms Block CD95- and TRAIL Death Receptor-induced Gene Induction Irrespective of Processing of Caspase-8 or cFLIP in the Death-inducing Signaling Complex
- (2011) Shyam M. Kavuri et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Multiple BH3 Mimetics Antagonize Antiapoptotic MCL1 Protein by Inducing the Endoplasmic Reticulum Stress Response and Up-regulating BH3-only Protein NOXA
- (2011) Tina C. Albershardt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BH3 mimetics activate multiple pro-autophagic pathways
- (2011) S A Malik et al. ONCOGENE
- ABT-737 synergizes with Bortezomib to kill melanoma cells
- (2011) S. N. Reuland et al. Biology Open
- Molecular biology of Bax and Bak activation and action
- (2010) Dana Westphal et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition
- (2010) P. S. Bachmann et al. BLOOD
- The BH3 Mimetic ABT-737 Induces Cancer Cell Senescence
- (2010) Jin H. Song et al. CANCER RESEARCH
- Targeting mitochondria for cancer therapy
- (2010) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Mitochondria and cell death: outer membrane permeabilization and beyond
- (2010) Stephen W. G. Tait et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Role of Mitochondria in Apoptosis
- (2009) Chunxin Wang et al. Annual Review of Genetics
- SnapShot: BCL-2 Proteins
- (2009) J. Marie Hardwick et al. CELL
- Different forms of cell death induced by putative BCL2 inhibitors
- (2009) M Vogler et al. CELL DEATH AND DIFFERENTIATION
- TRAF2 Must Bind to Cellular Inhibitors of Apoptosis for Tumor Necrosis Factor (TNF) to Efficiently Activate NF-κB and to Prevent TNF-induced Apoptosis
- (2009) James E. Vince et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment
- (2009) Peter Geserick et al. JOURNAL OF CELL BIOLOGY
- Mcl-1 Is Required for Melanoma Cell Resistance to Anoikis
- (2009) K. Boisvert-Adamo et al. MOLECULAR CANCER RESEARCH
- XIAP discriminates between type I and type II FAS-induced apoptosis
- (2009) Philipp J. Jost et al. NATURE
- BH3 Mimetic ABT-737 Potentiates TRAIL-Mediated Apoptotic Signaling by Unsequestering Bim and Bak in Human Pancreatic Cancer Cells
- (2008) S. Huang et al. CANCER RESEARCH
- ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
- (2008) C. Tse et al. CANCER RESEARCH
- Targeting XIAP Bypasses Bcl-2-Mediated Resistance to TRAIL and Cooperates with TRAIL to Suppress Pancreatic Cancer Growth In vitro and In vivo
- (2008) M. Vogler et al. CANCER RESEARCH
- Targeting the Bcl-2-regulated apoptosis pathway by BH3 mimetics: a breakthrough in anticancer therapy?
- (2008) V Labi et al. CELL DEATH AND DIFFERENTIATION
- Induction of Noxa Sensitizes Human Colorectal Cancer Cells Expressing Mcl-1 to the Small-Molecule Bcl-2/Bcl-xL Inhibitor, ABT-737
- (2008) K. Okumura et al. CLINICAL CANCER RESEARCH
- FLIP ing the coin? Death receptor-mediated signals during skin tumorigenesis
- (2008) Martin Leverkus et al. EXPERIMENTAL DERMATOLOGY
- ABT-737 Induces Expression of the Death Receptor 5 and Sensitizes Human Cancer Cells to TRAIL-induced Apoptosis
- (2008) Jin H. Song et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cysteine 62 of Bax Is Critical for Its Conformational Activation and Its Proapoptotic Activity in Response to H2O2-induced Apoptosis
- (2008) Chunlai Nie et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BH3 Mimetic ABT-737 and a Proteasome Inhibitor Synergistically Kill Melanomas through Noxa-Dependent Apoptosis
- (2008) Leslie A. Miller et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?
- (2008) Jerry E. Chipuk et al. TRENDS IN CELL BIOLOGY
- NF-κB Inhibition Reveals Differential Mechanisms of TNF Versus TRAIL-Induced Apoptosis Upstream or at the Level of Caspase-8 Activation Independent of cIAP2
- (2007) Philip Diessenbacher et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started